Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0L6OA
|
||||
Former ID |
DPR000023
|
||||
Drug Name |
BL-1020
|
||||
Synonyms |
BL 1020; Perphenazine 4-aminobutyrate; Butanoic acid, 4-amino-, 2-(4-(3-(2-chloro-10H-phenothiazin-10-yl)propyl)-1-piperazinyl)ethyl ester
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Schizophrenia [ICD9: 295; ICD10:F20] | Phase 2 | [536463] | ||
Company |
BioLineRx
|
||||
Structure |
Download2D MOL |
||||
Formula |
C25H34ClN4O3S-
|
||||
CAS Number |
CAS 1027512-25-9
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | D(2) dopamine receptor | Target Info | Antagonist | [536463] | |
Gamma-aminobutyric acid receptor | Target Info | Agonist | [536463] | ||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.